Diseases, Conditions, Syndromes

COVID-19 vaccine creates incentive to improve our health

While we wait for our turn to get vaccinated against SARS-CoV-2, we could—and probably should—use the time to make sure we bring our healthiest emotional and physical selves to the treatment, a new review of previous ...

Vaccination

EXPLAINER: US regulator weighs in on vaccine dosing debate

The first Americans vaccinated against COVID-19 are getting their second dose, while Britain has decided to postpone boosters and focus instead on giving more people a first shot—international differences that are adding ...

Diseases, Conditions, Syndromes

India OKs AstraZeneca and locally made COVID-19 vaccines

India authorized two COVID-19 vaccines on Sunday, paving the way for a huge inoculation program to stem the coronavirus pandemic in the world's second-most populous country.

Vaccination

FDA plans to OK 2nd COVID-19 vaccine after panel endorsement

The head of the Food and Drug Administration said late Thursday that his agency will move to quickly authorize the second COVID-19 vaccine to fight the pandemic, hours after the shot won the key endorsement of a government ...

Vaccination

The new COVID-19 vaccine: Answers to all the hard questions

With unprecedented speed and efficiency but without sacrificing scientific rigor, several highly effective vaccines have been developed to protect against SARS-CoV-2, the virus that causes COVID-19. Many countries, including ...

Diseases, Conditions, Syndromes

Could existing drugs be used against COVID-19?

Several drugs already approved by the U.S. Food and Drug Administration (FDA) could potentially be used to alleviate the symptoms of COVID-19, biomedical researchers at Université de Montréal have found.

Diseases, Conditions, Syndromes

US panel endorses widespread use of Pfizer COVID-19 vaccine

A U.S. government advisory panel endorsed widespread use of Pfizer's coronavirus vaccine Thursday, putting the country just one step away from launching an epic vaccination campaign against the outbreak that has killed close ...

Vaccination

US experts convene to decide whether to OK Pfizer vaccine

A U.S. government advisory panel convened on Thursday to decide whether to endorse large-scale use of Pfizer's COVID-19 vaccine to help conquer the outbreak that has killed close to 300,000 Americans.

page 1 from 9